FLEXUS BIOSCIENCES

flexus-biosciences-logo

Flexus is a privately-held biopharmaceutical company focused on the creation, development, and commercialization of novel anti-cancer therapeutics through an innovative application of unexploited insights in immunology. Founded in 2013, Flexus is headquartered in San Carlos, California.

#SimilarOrganizations #People #Financial #Website #More

FLEXUS BIOSCIENCES

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical

Founded:
2013-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.flexusbio.com

Total Employee:
11+

Status:
Active

Contact:
1(650) 489-9000

Email Addresses:
[email protected]

Total Funding:
66.2 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

innodia-logo

Innodia

Innodia is a privately held biopharmaceutical company with the mission of developing and bringing new drugs.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

Founder


terry-rosen_image

Terry Rosen

Investors List

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Venture Round - Flexus Biosciences

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Flexus Biosciences

the-column-group_image

The Column Group

The Column Group investment in Series B - Flexus Biosciences

celgene_image

Celgene

Celgene investment in Series B - Flexus Biosciences

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series A - Flexus Biosciences

Official Site Inspections

http://www.flexusbio.com

  • Host name: 198.155.190.60
  • IP address: 198.155.190.60
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Flexus Biosciences"

Flexus Biosciences - Crunchbase Company Profile

Flexus is a privately-held biopharmaceutical company focused on the creation, development, and commercialization of novel anti-cancer therapeutics through an innovative application of unexploited insights in immunology.See details»

Flexus Biosciences - Ownership and Business Overview - Mergr

United States, www.flexusbio.com. Profile Investors (1) Analytics Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule โ€ฆSee details»

Flexus Biosciences Company Profile 2024: Valuation, โ€ฆ

Flexus Biosciences General Information Description. Developer of small-molecule cancer therapeutics designed to target regulatory T cells. The company is focused on the creation, development and commercialization of novel anti โ€ฆSee details»

Flexus Biosciences - LinkedIn

Flexus Biosciences | 225 followers on LinkedIn. Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 2015. | Founded in 2013, Flexus is a privately-held ...See details»

Flexus Biosciences Inc - Company Profile and News

Company profile page for Flexus Biosciences Inc including stock price, company news, executives, board members, and contact informationSee details»

Flexus Biosciences, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Flexus Biosciences, Inc. of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»

Flexus Biosciences - Products, Competitors, Financials, Employees ...

Headquarters Location. 75 Shoreway Road Suite D. San Carlos, California, 94070, United States. 650-489-9000See details»

Flexus Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Flexus Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Flexus Biosciences Overview | SignalHire Company Profile

Phone Number: 1(650) 489-9000: Flexus Biosciences industries Biotech, Biotechnology: Flexus Biosciences Employees SizeSee details»

Organization | Flexus Biosciences - Purdue University

Founded: San Carlos CA United States (2013) Status: Acquired by Bristol-Myers Squibb (2015)See details»

Flexus Biosciences, Inc.:Company Profile & Technical Research ...

Flexus Biosciences, Inc. is headquartered in United States California. Flexus Biosciences, Inc. was founded in 2013. Flexus Biosciences, Inc. has a total of 101 patentsSee details»

Flexus Biosciences Asset Profile - Preqin

Founded in 2013 and based in California, US, Flexus Biosciences, Inc. is a biotechnology company that focuses on the creation, development and commercializat...See details»

Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline โ€ฆ

โ€œBristol Myers Squibb is a recognized leader in the cancer immunotherapy field, and we are delighted with the opportunity to have their organization advance the development of our โ€ฆSee details»

BMS Agrees to Acquire Flexus Biosciences for $1.25 Bn; Signs ...

Feb 23, 2015 Bristol-Myers Squibb has signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Flexus Biosciences, a privately held โ€ฆSee details»

Bristol Myers Squibb - Bristol-Myers Squibb Completes Previously ...

Apr 8, 2015 Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has completed the previously announced planned acquisition of Flexus Biosciences, Inc. The โ€ฆSee details»

Flexus Bioscience | CipherBio

Explore Flexus Bioscience's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Working at Flexus Biosciences - Glassdoor

The acquisition will give Bristol-Myers Squibb full rights to F001287, Flexusโ€™ lead preclinical small molecule IDO1-inhibitor targeted for IND filing in the second half of 2015.See details»

What is Flexus Biosciences? Company Culture, Mission, Values

See what employees say it's like to work at Flexus Biosciences. Salaries, reviews, and more - all posted by employees working at Flexus Biosciences.See details»

Working at Flexus Biosciences | Glassdoor

See what employees say it's like to work at Flexus Biosciences. Salaries, reviews, and more - all posted by employees working at Flexus Biosciences.See details»

Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline โ€ฆ

Feb 23, 2015 "Bristol Myers Squibb is a recognized leader in the cancer immunotherapy field, and we are delighted with the opportunity to have their organization advance the development โ€ฆSee details»

linkstock.net © 2022. All rights reserved